Christopher C. Caillouet

Array ( [id] => 345156 [patent_doc_number] => 07498343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Mycobacterial inhibitors' [patent_app_type] => utility [patent_app_number] => 11/007026 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14434 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498343.pdf [firstpage_image] =>[orig_patent_app_number] => 11007026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913003 [patent_doc_number] => 20050176761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Tetrahydroisoquinoline derivatives for treating protein trafficking diseases' [patent_app_type] => utility [patent_app_number] => 11/006042 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20260 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176761.pdf [firstpage_image] =>[orig_patent_app_number] => 11006042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585694 [patent_doc_number] => 07446202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Cyanine dye compounds' [patent_app_type] => utility [patent_app_number] => 11/005860 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23976 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446202.pdf [firstpage_image] =>[orig_patent_app_number] => 11005860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 755260 [patent_doc_number] => 07019143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Antimicrobial quinolones, their compositions and uses' [patent_app_type] => utility [patent_app_number] => 11/003588 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10687 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019143.pdf [firstpage_image] =>[orig_patent_app_number] => 11003588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989426 [patent_doc_number] => 20070155767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Sulfone substituted imidazo ring ethers' [patent_app_type] => utility [patent_app_number] => 10/596117 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47820 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155767.pdf [firstpage_image] =>[orig_patent_app_number] => 10596117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918755 [patent_doc_number] => 20050096316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Quinoline derivatives(2)' [patent_app_type] => utility [patent_app_number] => 10/999180 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26243 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096316.pdf [firstpage_image] =>[orig_patent_app_number] => 10999180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991460 [patent_doc_number] => 20050090497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Novel ester or amide derivatives' [patent_app_type] => utility [patent_app_number] => 10/992134 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5705 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090497.pdf [firstpage_image] =>[orig_patent_app_number] => 10992134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558010 [patent_doc_number] => 07157408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Quinoline fungicides' [patent_app_type] => utility [patent_app_number] => 10/990831 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3024 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157408.pdf [firstpage_image] =>[orig_patent_app_number] => 10990831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7603358 [patent_doc_number] => 07235674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/989057 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19126 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235674.pdf [firstpage_image] =>[orig_patent_app_number] => 10989057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806824 [patent_doc_number] => 07420059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'HMG-CoA reductase inhibitors and method' [patent_app_type] => utility [patent_app_number] => 10/989138 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40309 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/420/07420059.pdf [firstpage_image] =>[orig_patent_app_number] => 10989138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4434098 [patent_doc_number] => 07897767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Oxime substituted imidazoquinolines' [patent_app_type] => utility [patent_app_number] => 10/595792 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59848 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897767.pdf [firstpage_image] =>[orig_patent_app_number] => 10595792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194442 [patent_doc_number] => 20070082926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Novel polymorphs of racemic, dextrorotatory, and levorotatory enationers of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo- quinoline-3-carboxylic acid hydrochloride and mesylate salts' [patent_app_type] => utility [patent_app_number] => 10/578371 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 18592 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082926.pdf [firstpage_image] =>[orig_patent_app_number] => 10578371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833644 [patent_doc_number] => 07396934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Process for preparing 3-fluoroquinolines' [patent_app_type] => utility [patent_app_number] => 10/985533 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4992 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396934.pdf [firstpage_image] =>[orig_patent_app_number] => 10985533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906174 [patent_doc_number] => 20050101569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Methods and compositions for selectin inhibition' [patent_app_type] => utility [patent_app_number] => 10/984522 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25638 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101569.pdf [firstpage_image] =>[orig_patent_app_number] => 10984522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 567773 [patent_doc_number] => 07465799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Methods and compositions for selectin inhibition' [patent_app_type] => utility [patent_app_number] => 10/984093 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14730 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465799.pdf [firstpage_image] =>[orig_patent_app_number] => 10984093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688847 [patent_doc_number] => 20070105851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/579938 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14451 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105851.pdf [firstpage_image] =>[orig_patent_app_number] => 10579938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163525 [patent_doc_number] => 20050085504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/980990 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11783 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085504.pdf [firstpage_image] =>[orig_patent_app_number] => 10980990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 810391 [patent_doc_number] => 07417148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => '4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)' [patent_app_type] => utility [patent_app_number] => 10/980097 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5745 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/417/07417148.pdf [firstpage_image] =>[orig_patent_app_number] => 10980097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145710 [patent_doc_number] => 20050119269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Heterocyclic compounds and methods of making and using thereof' [patent_app_type] => utility [patent_app_number] => 10/976284 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 140950 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119269.pdf [firstpage_image] =>[orig_patent_app_number] => 10976284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005831 [patent_doc_number] => 20050171144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Imidazo[1,2-a] pyridine anxiolytics' [patent_app_type] => utility [patent_app_number] => 10/976331 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19815 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171144.pdf [firstpage_image] =>[orig_patent_app_number] => 10976331 [rel_patent_id] =>[rel_patent_doc_number] =>)